financetom
VTRS
financetom
/
Healthcare
/
VTRS
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Viatris Inc.VTRS
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Viatris Inc. operates as a healthcare company worldwide.

The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs).

The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health.

It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions.

The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies.

It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names.

The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Latest News >
GLOBAL MARKETS-Stocks, Canadian dollar slip as Trump announces tariffs on imports from Canada
GLOBAL MARKETS-Stocks, Canadian dollar slip as Trump announces tariffs on imports from Canada
Jul 11, 2025
* US stocks end lower * Canadian dollar dips after Trump announces tariffs * Bitcoin hits record high, gold strong (Updates with closing US market levels) By Caroline Valetkevitch and Chibuike Oguh NEW YORK, July 11 (Reuters) - Major stock indexes were slightly lower on Friday as U.S. President Donald Trump's announcement of tariffs on imports from Canada fanned worries...
Hagerty Insider Sold Shares Worth $1,510,189, According to a Recent SEC Filing
Hagerty Insider Sold Shares Worth $1,510,189, According to a Recent SEC Filing
Jul 11, 2025
05:13 PM EDT, 07/11/2025 (MT Newswires) -- Robert I Kauffman, Director, on July 09, 2025, sold 149,975 shares in Hagerty ( HGTY ) for $1,510,189. Following the Form 4 filing with the SEC, Kauffman has control over a total of 3,566,583 Class A common shares of the company, with 67,302 shares held directly and 3,499,281 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1840776/000184077625000196/xslF345X05/wk-form4_1752268117.xml...
Wall Street Retreats as Investors Monitor Tariffs Updates, Bank Earnings Loom
Wall Street Retreats as Investors Monitor Tariffs Updates, Bank Earnings Loom
Jul 11, 2025
05:11 PM EDT, 07/11/2025 (MT Newswires) -- The S&P 500 and the Nasdaq Composite fell on Friday from fresh highs as investors closely watched updates on tariffs and awaited big banks to report results next week. The S&P 500 fell 0.3% to 6,259.8 while the Nasdaq slipped 0.2% to 20,585.5, after the two indices notched record closing levels on Thursday....
Pegasystems Insider Sold Shares Worth $2,400,300, According to a Recent SEC Filing
Pegasystems Insider Sold Shares Worth $2,400,300, According to a Recent SEC Filing
Jul 11, 2025
05:12 PM EDT, 07/11/2025 (MT Newswires) -- Alan Trefler, 10% Owner, Director, CEO & Chairman, on July 09, 2025, sold 45,000 shares in Pegasystems ( PEGA ) for $2,400,300. Following the Form 4 filing with the SEC, Trefler has control over a total of 77,778,712 common shares of the company, with 33,051,692 shares held directly and 44,727,020 controlled indirectly. SEC...
Copyright 2023-2025 - www.financetom.com All Rights Reserved